Patent application number | Description | Published |
20090247746 | Fused heterocyclic compound - The present invention provides a glucokinase activator containing a compound represented by the formula (I): | 10-01-2009 |
20090286975 | Indole compound - The purpose of the present invention is to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. | 11-19-2009 |
20100137610 | Indole compound - The purpose of the present invention is to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. | 06-03-2010 |
20100144702 | INDOLE COMPOUND - The purpose of the present invention is to provide a glucokinase activator useful as a pharmaceutical agent such as an agent for the prophylaxis or treatment of diabetes, obesity and the like. The present invention provides a glucokinase activator containing a compound represented by the formula (I): wherein R | 06-10-2010 |
20110190335 | NITROGENATED 5-MEMBERED HETEROCYCLIC COMPOUND - The purpose of the present invention is to provide a glucokinase activator which is useful as a pharmaceutical agent such as agents for the prophylaxis or treatment of diabetes, obesity and the like, and the like. | 08-04-2011 |
20120077799 | HETEROCYCLIC COMPOUND AND USE THEREOF - Provided is a compound represented by the formula (I): | 03-29-2012 |
Patent application number | Description | Published |
20130116214 | HETEROCYCLIC RING COMPOUND - The present invention provides a compound having a muscle cell or adipocyte differentiation regulating action, useful for the prophylaxis or treatment of diseases such as diabetes, obesity, dyslipidemia and the like, and the like, and having superior efficacy. | 05-09-2013 |
20130184266 | HETEROCYCLIC COMPOUND AND USE THEREOF - Provided is a compound represented by the formula (I): | 07-18-2013 |
20130190291 | HETEROCYCLIC COMPOUND AND USE THEREOF - Provided is a compound represented by the formula (I): | 07-25-2013 |
20130296276 | HETEROCYCLIC RING COMPOUND - The present invention provides a compound having a muscle cell or adipocyte differentiation regulating action, useful for the prophylaxis or treatment of diseases such as diabetes, obesity, dyslipidemia and the like, and the like, and having superior efficacy. | 11-07-2013 |
20140024650 | SULFONAMIDE DERIVATIVE AND USE THEREOF - Provided is a compound having an AMPA receptor function enhancing action, and useful as a prophylactic or therapeutic drug for depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. A compound represented by the formula (I): | 01-23-2014 |
20140080817 | HETEROCYCLIC COMPOUND AND USE THEREOF - Provided is a compound represented by the formula (I): | 03-20-2014 |
20150073137 | HETEROCYCLIC COMPOUND AND USE THEREOF - Provided is a compound represented by the formula (I): | 03-12-2015 |